JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davies, R. F.
Right arrow Articles by Beanlands, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davies, R. F.
Right arrow Articles by Beanlands, D. S.

The Journal of Thoracic and Cardiovascular Surgery, Vol 96, 634-641, Copyright © 1988 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations

RF Davies, LM Dube, N Mousseau, I McGilveray and DS Beanlands
University of Ottawa Heart Institute, Ontario, Canada.

This study examined the effect of changes in plasma concentrations of total protein, albumin, alpha 1-acid glycoprotein, and free fatty acids occurring after heart operations on the protein binding of chemically basic drugs. Plasma protein and free fatty acid concentrations were measured simultaneously with in vitro determinations of the protein binding of lidocaine, quinidine, and propranolol: immediately before operation, immediately on weaning from cardiopulmonary bypass, on arrival in the recovery room, and 12, 24, 72, and 120 hours postoperatively. Initial decreases in the concentrations of all proteins were followed by a rise in alpha 1-acid glycoprotein to 254% of baseline at 72 to 120 hours. The free fractions of drug were initially increased to 168% of baseline for lidocaine, 206% for quinidine, and 200% for propranolol and fell progressively with time, reaching sustained troughs of 65% for lidocaine, 50% for quinidine, and 57% for propranolol at 72 to 120 hours. Regression analysis indicated a major influence of changing alpha 1-acid glycoprotein concentrations on free fractions of all three drugs, with a smaller effect of albumin that reached statistical significance only for lidocaine. There were no significant perioperative changes in plasma concentrations of free fatty acids when the in vitro effects of heparin were controlled. In conclusion, sequential changes in plasma protein concentrations after cardiac operations predictably alter the protein binding of lidocaine, quinidine, and propranolol and should be considered when interpreting total plasma drug concentrations.


This article has been cited by other articles:


Home page
PerfusionHome page
P. Lonnqvist and L. Herngren
Effects of pronounced haemodilution on the plasma protein binding of lidocaine
Perfusion, January 1, 1995; 10(1): 17 - 20.
[Abstract] [PDF]


Home page
PerfusionHome page
P.-A. Lonnqvist
Alpha-1-acidglycoprotein levels in infants during cardiopulmonary bypass and deep hypothermic circulatory arrest
Perfusion, October 1, 1991; 6(4): 261 - 264.
[Abstract] [PDF]


Home page
PerfusionHome page
A. Lonnqvist and J. Dobbs
Glucose, sodium and plasma protein levels during deep hypothermic circulatory arrest using a low volume, minimal glucose priming solution based on washed packed red cells
Perfusion, January 1, 1991; 6(1): 23 - 30.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 by The American Association for Thoracic Surgery.